LISANTI CAPITAL GROWTH, LLC – Neurocrine Biosciences, Inc. Transaction History
LISANTI CAPITAL GROWTH, LLC portfolio value:
$9.27M
portfolio value
LISANTI CAPITAL GROWTH, LLC quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +55.01% | 31K shares | 3.78M | $106.21 | 87.35K |
| Q2 2022 | share | Increase | +33.50% | 14.14K shares | 1.53M | $97.48 | 56.35K |
| Q1 2022 | share | Increase | 0.00% | 42.21K shares | 3.95M | $93.75 | 42.21K |
| Q3 2020 | share | Decrease | -100.00% | -15.31K shares | -1.86M | $96.16 | 0 |
| Q2 2020 | share | Increase | +57.97% | 5.62K shares | 1.02M | $122 | 15.31K |
| Q1 2020 | share | Decrease | -7.10% | -741 shares | -283K | $86.55 | 9.69K |
| Q4 2019 | share | Increase | +15.06% | 1.36K shares | 305K | $107.49 | 10.43K |
| Q3 2019 | share | Increase | 0.00% | 9.07K shares | 817K | $90.11 | 9.07K |
| Q4 2018 | share | Decrease | -100.00% | -7.12K shares | -875K | $71.41 | 0 |
| Q3 2018 | share | Decrease | -1.52% | -110 shares | 165K | $122.95 | 7.12K |
| Q2 2018 | share | Decrease | -35.48% | -3.97K shares | -219K | $98.24 | 7.23K |
| Q1 2018 | share | Increase | +32.53% | 2.75K shares | 273K | $82.93 | 11.20K |
| Q4 2017 | share | Increase | 0.00% | 8.45K shares | 656K | $77.59 | 8.45K |
| Q4 2016 | share | Decrease | -100.00% | -20.42K shares | -1.03M | $38.7 | 0 |
| Q3 2016 | share | Increase | +78.46% | 8.98K shares | 514K | $50.64 | 20.42K |
| Q2 2016 | share | Decrease | -11.72% | -1.52K shares | 7K | $45.45 | 11.44K |
| Q1 2016 | share | Decrease | -49.15% | -12.53K shares | -930K | $39.55 | 12.96K |